Enteric toxins and pathogen-associated molecules

Enteric toxins and pathogen-associated molecules represent a broad class of substances produced by or derived from microorganisms within the gastrointestinal tract, including bacterial exotoxins (e.g., Shiga toxin), endotoxins (e.g., lipopolysaccharide or LPS), and various pathogen-associated molecular patterns (PAMPs) (Enteromed, 2023; PMID: 31454014). These molecules are central to the pathogenesis of gastrointestinal disorders and systemic inflammation by damaging the intestinal epithelial barrier and triggering innate immune responses via receptors like TLR4 (PMID: 28244546). In clinical practice, these molecules are targeted by intestinal adsorbents such as polymethylsiloxane polyhydrate (Enterosgel) and AST-120, which physically sequester the toxins to prevent their systemic translocation and local mucosal irritation (PMID: 29156145). This therapeutic approach is particularly relevant in managing acute infectious diarrhea, irritable bowel syndrome, and the uremic complications of chronic kidney disease where gut-derived toxins contribute to disease progression (PMID: 30265408). By neutralizing these harmful agents within the gut lumen, these drugs help restore intestinal homeostasis and reduce the systemic inflammatory burden.

Other names

Intestinal toxinsBacterial endotoxinsBacterial exotoxinsPathogen-associated molecular patternsPAMPsMicrobial-derived toxinsGut-derived uremic toxins

Physical adsorption and sequestration of toxins and PAMPs within the gastrointestinal lumen to prevent mucosal damage and systemic absorption.